Congenital myaesthenic syndrome
Gene: COL13A1EnsemblGeneIds (GRCh38): ENSG00000197467
EnsemblGeneIds (GRCh37): ENSG00000197467
OMIM: 120350, Gene2Phenotype
COL13A1 is in 4 panels
5 reviews
Achchuthan Shanmugasundram (Genomics England Curator)
The 'treatable' tag has been added as salbutamol alone or in combination with 3,4-DAP was reported effective in all tested patients (PMID:31449669).Created: 28 Mar 2023, 1:14 p.m. | Last Modified: 28 Mar 2023, 1:14 p.m.
Panel Version: 4.1
Publications
Louise Daugherty (Genomics England Curator)
Review and rating from Michael Oldridge (Oxford Medical Genetics Laboratories Oxford University Hospitals NHS Foundation Trust), submitted by Tracy Lester (Oxford Medical Genetics Laboratories Oxford University Hospitals NHS Foundation Trust) on behalf of Wessex and West Midlands GLH for GMS Neurology specialist test group.Created: 30 Apr 2019, 9:30 a.m.
Michael Oldridge (NHS)
see PanelAppCreated: 29 Apr 2019, 4:33 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Congenital myasthenic syndrome type 19; Myasthenic syndrome, congenital, 19, 616720
Rebecca Foulger (Genomics England curator)
Comment on list classification: Updated rating from Amber to Green: 1 green review from expert, plus 2 unrelated cases with additional support from mouse model.Created: 7 Feb 2017, 4:25 p.m.
Comment on list classification: Updated rating from Grey to Amber. 1 green review (from gene submitter). 2 unrelated cases reported so far, mouse model demonstrates role of COL13A1 in NMJ development, and probable DD-G2P gene.Created: 2 Feb 2017, 12:02 p.m.
Probable DD-G2P gene for Congenital Myasthenic Syndrome Type 19.Created: 2 Feb 2017, noon
Mouse model: PMID:20844119 (Latvanlehto et al., 2010) describe post- and presynaptic defects in Col13a1(-/-) mice and suggest that collagen XIII plays an autocrine role in postsynaptic maturation of the NMJ.Created: 2 Feb 2017, 11:59 a.m.
In 3 patients from 2 unrelated families with congenital myasthenic syndrome-19 (OMIM:616720), Logan et al. (2015, (PMID:26626625) identified 2 different homozygous truncating mutations in COL13A1.Created: 2 Feb 2017, 11:53 a.m.
Comment on mode of inheritance: Mode of inheritance confirmed by OMIM.Created: 2 Feb 2017, 11:43 a.m.
David Beeson (Oxford University)
Covered by the OXford Congenital Myasthenia ServiceCreated: 26 Jan 2017, 12:12 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Congenital myasthenic syndrome type 19
Publications
- PMID: 26626625
Variants in this GENE are reported as part of current diagnostic practice
Details
- Mode of Inheritance
- BIALLELIC, autosomal or pseudoautosomal
- Sources
-
- NHS GMS
- Wessex and West Midlands GLH
- Expert Review Green
- Phenotypes
-
- Myasthenic syndrome, congenital, 19, OMIM:616720
- Tags
- OMIM
- 120350
- Clinvar variants
- Variants in COL13A1
- Penetrance
- Complete
- Publications
- Panels with this gene
History Filter Activity
Added Tag
Achchuthan Shanmugasundram (Genomics England Curator)Tag treatable tag was added to gene: COL13A1.
Set Phenotypes
Ivone Leong (Genomics England Curator)Phenotypes for gene: COL13A1 were changed from Congenital myasthenic syndrome type 19; Myasthenic syndrome, congenital, 19, 616720 to Myasthenic syndrome, congenital, 19, OMIM:616720
Set publications
Louise Daugherty (Genomics England Curator)Publications for gene: COL13A1 were set to PMID: 26626625
Added New Source
Louise Daugherty (Genomics England Curator)Source NHS GMS was added to COL13A1.
Added New Source, Status Update
Louise Daugherty (Genomics England Curator)Source Wessex and West Midlands GLH was added to COL13A1. Rating Changed from Green List (high evidence) to Green List (high evidence)
panel promoted to version 1
Rebecca Foulger (Genomics England curator)22 February 2017: Reviews were assessed, and panel was revised according to expert review and additional curation.
Gene classified by Genomics England curator
Rebecca Foulger (Genomics England curator)This gene has been classified as Green List (High Evidence).
Gene classified by Genomics England curator
Rebecca Foulger (Genomics England curator)This gene has been classified as Amber List (Moderate Evidence).
Set Mode of Inheritance
Rebecca Foulger (Genomics England curator)Mode of inheritance for COL13A1 was changed to BIALLELIC, autosomal or pseudoautosomal
Set Phenotypes
Rebecca Foulger (Genomics England curator)Phenotypes for COL13A1 were set to Congenital myasthenic syndrome type 19; Myasthenic syndrome, congenital, 19, 616720
Added New Source
David Beeson (Oxford University)COL13A1 was added to Congenital myaestheniapanel. Sources: Literature,Eligibility statement prior genetic testing
Created
David Beeson (Oxford University)COL13A1 was created by [email protected]